# Coherus Oncology, Inc.: Form 8-K/A, filed May 21, 2024

- Company: [Coherus Oncology, Inc.](/companies/chrs.md) (CIK 1512762)
- Form: 8-K/A
- Filed: 2024-05-21
- Accepted by EDGAR: May 21, 2024, 17:14 ET
- Period: 2024-05-08
- Accession: 0001558370-24-008542
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1512762/000155837024008542/chrs-20240508x8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1512762/000155837024008542/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1512762/000155837024008542/chrs-20240508x8ka.htm

Filed May 21, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-008542. Last ingested by Listed: Oct 29, 2026, 08:11 ET. No prices; not investment advice.